Skip to the page Regenerative Doctor Directory Question cards before regenerative treatment Take questions to a visit Evidence cards Make the proof match the plan. Ask for the source behind the claim. Keep the exact product and your own problem in view while reading it. Ask. Check. Keep the answer. An official-sounding badge Ask what has actually been checked. The FDA is the Food and Drug Administration, the U.S. drug agency. If a page uses its name, ask what the wording means. Evidence card · Business listing An FDA business listing is not approval. A business registered with the FDA has put its details on the agency’s list. This does not mean the FDA approves the business or its medicines. Open the source note An FDA business listing is not approval. — source note The FDA does not approve health care providers, including doctor offices. Read the rule on business listings FDA’s guide to approval claims Evidence card · Product codes A product number is not proof of approval. NDC means National Drug Code, a number identifying a drug product in the FDA’s list. That number does not establish FDA approval for the product. Open the source note A product number is not proof of approval. — source note If an offer points to an “NDC” number, ask for proof of approval for that exact product. A code or a picture of a listing is not that proof. FDA’s explanation of its product-code list A made-to-order medicine Did studies test this exact medicine? A pharmacist or doctor can prepare a patient’s medicine to order. That process is called compounding. Evidence card · Compounding It has no FDA approval. Compounded medicines are not FDA-approved. Before they go on sale, the FDA has not assessed how well they are made, whether they are safe, or whether they work. Open the source note It has no FDA approval. — source note Ask whether studies tested the particular medicine the pharmacy would make for you, and what is still unknown. FDA’s explanation of medicines made to order A gap in the research Missing information is still missing. If BPC-157 is in your offer, these gaps matter. Ask what problem it is meant to treat and why it is being proposed. Evidence card · Limits of knowledge Ask for an honest account of the gap. BPC-157 is a peptide with no U.S. FDA approval. The FDA found little or no information about BPC-157’s safety in people. Open the source note Ask for an honest account of the gap. — source note The FDA does not have enough information to know whether BPC-157 could harm people when taken in the ways being proposed. FDA’s ingredient concerns Ask it plainly What has been tested in people with my problem, and what is still unknown? Keep the study beside the offer Ask what the source can show. Was the study done in people with my condition? Was the tested product the same as the one being offered? What was it compared with? What change did the study measure? Can you send me the full source so I can read it? Ask the health professional checking your health to explain the result in everyday words. A link is a starting point for that conversation. Keep going Know when to pause Keep these guide cards beside you. This site runs no clinic and sells nothing. Facts checked: September 17, 2026; September 26, 2026. Read this page as text Full kit as text Back to the page start Home Treatment Credentials Visit Cost Evidence Pause